Hui‐Ming Chang
- Molecular Biology top 10%
- Immunology top 5%
- Cardiology and Cardiovascular Medicine top 5%
- Oncology top 10%
- Epidemiology top 10%
- Co-authors
- Edward T.H. YehTiziano M. ScarabelliRohit MoudgilTochukwu OkwuosaTetsu KamitaniR DeGasperiEiji SugiyamaE T Yeh
- Topics
- Complement system in diseases (8 papers)Trypanosoma species research and implications (8 papers)Chemotherapy-induced cardiotoxicity and mitigation (8 papers)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Hui‐Ming Chang
47 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 111
- Molecular Biology 1.0k
- Immunology 531
- Cardiology and Cardiovascular Medicine 486
- Oncology 362
- Epidemiology 331
Countries citing papers authored by Hui‐Ming Chang
This map shows the geographic impact of Hui‐Ming Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Ming Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Ming Chang more than expected).
Fields of papers citing papers by Hui‐Ming Chang
This network shows the impact of papers produced by Hui‐Ming Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Ming Chang. The network helps show where Hui‐Ming Chang may publish in the future.
Co-authorship network of co-authors of Hui‐Ming Chang
This figure shows the co-authorship network connecting the top 25 collaborators of Hui‐Ming Chang. A scholar is included among the top collaborators of Hui‐Ming Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui‐Ming Chang. Hui‐Ming Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | ANTHRACYCLINE-INDUCED CARDIOTOXICITY: MECHANISM AND PREVENTION. | 1 |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 30 | |
| 5 | 15 | |
| 6 | 21 | |
| 7 | 186 | |
| 8 | 262 | |
| 9 | 12 | |
| 10 | 19 | |
| 11 | 2 | |
| 12 | 23 | |
| 13 | 20 | |
| 14 | 15 | |
| 15 | 34 | |
| 16 | 2 | |
| 17 | 63 | |
| 18 | 13 | |
| 19 | 60 | |
| 20 | 154 |
About Hui‐Ming Chang
Hui‐Ming Chang is a scholar working on Nephrology, Anesthesiology and Pain Medicine and Immunology, having authored 49 papers that have together received 2.1k indexed citations. Recurring topics across this work include Complement system in diseases (8 papers), Trypanosoma species research and implications (8 papers) and Chemotherapy-induced cardiotoxicity and mitigation (8 papers). The work is most often cited by research in Immunology (531 citations), Cardiology and Cardiovascular Medicine (486 citations) and Nephrology (111 citations). Hui‐Ming Chang has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Edward T.H. Yeh, Tiziano M. Scarabelli, Rohit Moudgil, Tochukwu Okwuosa, Tetsu Kamitani, R DeGasperi, Eiji Sugiyama, E T Yeh, Masaharu Urakaze and Ichiro Okura. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.